MedPath

Treatment of common warts with topical solution of potassium hydroxide 15%

Phase 2
Conditions
Common wart.
Verruca Vulgaris
Registration Number
IRCT2014081118765N1
Lead Sponsor
Ahvaz Jundishapur University of Medical Sciences, Vice Chancellor
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
29
Inclusion Criteria

patient who have common wart with diameter less than 5 mm, on the hand or foot bilaterally.
Exclusion criteria: pregnancy; lactation; treatment during one recent month; secondary skin infection

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduced size of Common warts. Timepoint: Before intervention. Every week from starting of intervention to disappearance of all warts. Two months after the end of intervention. Method of measurement: observation; Ruler.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Before intervention. Every week from starting of intervention to disappearance of all warts. Two months after the end of intervention. Method of measurement: observation.
© Copyright 2025. All Rights Reserved by MedPath